Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 

Question 4: Short-term Objective B

green dot 4SB. Standardize and validate at least 20 model systems (e.g., cellular and/or animal) that replicate features of ASD and will allow identification of specific molecular targets or neural circuits amenable to existing or new interventions by 2012. IACC Recommended Budget: $75,000,000 over 5 years.

Projects Found: 102
Total Funding: 17006996
Records
Project Title Funding Funding Institution

Project Title

Neural and cognitive mechanisms of autism
$0

Funding

0

Institution

Massachusetts Institute of Technology

Project Title

The Role of Cation/Proton Exchanger NHE9 in Autism
$62,500

Funding

62500

Institution

University of California, San Francisco

Project Title

Rebuilding Inhibition in the Autistic Brain
$0

Funding

0

Institution

Brandeis University

Project Title

Examination of the mGluR-mTOR pathway for the identification of potential therapeutic targets to treat fragile X
$0

Funding

0

Institution

University of Pennsylvania

Project Title

Novel therapeutic targets to treat social behavior deficits in autism and related disorders
$0

Funding

0

Institution

University of Texas Health Science Center, San Antonio

Project Title

Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes
$0

Funding

0

Institution

University of North Carolina

Project Title

Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes
$0

Funding

0

Institution

University of North Carolina

Project Title

Preclinical testing of novel oxytocin receptor activators in models of autism phenotypes
$0

Funding

0

Institution

University of North Carolina

Project Title

16p11.2 deletion mice: Autism-relevant phenotypes and treatment discovery
$200,000

Funding

200000

Institution

Stanford University

Project Title

PsychoGenics Inc.
$218,567

Funding

218567

Institution

PsychoGenics Inc.

 
Back to Top